Colorectal Cancer Membrane Protein Interactomics [A Major Discriminator Of Clinical Outcome]
Funder
National Health and Medical Research Council
Funding Amount
$643,778.00
Summary
This project studies the molecular causes of colorectal cancer (CRC) malignancy because CRC is the 2nd most common malignancy by incidence and cause of death in the Western world. It currently results in 13.1% of Australian cancer deaths. The aim of this NHMRC project is to gain a detailed understanding of how particular cell membrane proteins interact with each to give cancer cells the ability to invade and spread.
Characterisation Of The Tumour Suppressor Function Of Caspase-2
Funder
National Health and Medical Research Council
Funding Amount
$605,096.00
Summary
Aberrant cell death (apoptosis) is associated with many diseases including cancer. Apoptosis is mediated by a group of enzymes called caspases. Recently we have discovered that one of these enzymes, caspase-2, acts as a tumour suppressor. We now wish to validate this finding in several preclinical models of cancer and understand precisely how caspase-2 works to safeguard cells against cancer development. These studies will help better understand cancer and ways to treat it.